Cargando…
SARS-CoV-2: An Updated Review Highlighting Its Evolution and Treatments
Since the SARS-CoV-2 outbreak, pharmaceutical companies and researchers worldwide have worked hard to develop vaccines and drugs to end the SARS-CoV-2 pandemic. The potential pathogen responsible for Coronavirus Disease 2019 (COVID-19), SARS-CoV-2, belongs to a novel lineage of beta coronaviruses in...
Autores principales: | Zhang, Xirui, Yuan, Hao, Yang, Zipeng, Hu, Xiaoyu, Mahmmod, Yasser S., Zhu, Xiaojing, Zhao, Cuiping, Zhai, Jingbo, Zhang, Xiu-Xiang, Luo, Shengjun, Wang, Xiao-Hu, Xue, Mengzhou, Zheng, Chunfu, Yuan, Zi-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780920/ https://www.ncbi.nlm.nih.gov/pubmed/36560555 http://dx.doi.org/10.3390/vaccines10122145 |
Ejemplares similares
-
Multiomics and bioinformatics identify differentially expressed effectors in the brain of Toxoplasma gondii infected masked palm civet
por: Yuan, Hao, et al.
Publicado: (2023) -
Transcriptome Analysis of Testes and Uterus: Reproductive Dysfunction Induced by Toxoplasma gondii in Mice
por: Wang, Junjie, et al.
Publicado: (2020) -
Four Chemotherapeutic Compounds That Limit Blood-Brain-Barrier Invasion by Toxoplasma gondii
por: Yan, Zijing, et al.
Publicado: (2022) -
Future trajectory of SARS-CoV-2: Constant spillover back and forth between humans and animals
por: Cui, Xinhua, et al.
Publicado: (2023) -
Unveiling of brain transcriptome of masked palm civet (Paguma larvata) with chronic infection of Toxoplasma gondii
por: Yuan, Hao, et al.
Publicado: (2022)